GUIDED THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $22.0K | $-5.4M | $643.0K |
| FY2022 | $0 | $-2.9M | $2.3M |
| FY2023 | — | $-3.8M | $591.0K |
| FY2024 | — | $-4.9M | $388.0K |
| FY2025 | — | $-6.0M | $63.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $22.0K | $-5.4M | $643.0K |
| FY2022 | $0 | $-2.9M | $2.3M |
| FY2023 | — | $-3.8M | $591.0K |
| FY2024 | — | $-4.9M | $388.0K |
| FY2025 | — | $-6.0M | $63.0K |